Research into fluorescent carbon nanoparticles isolated from two of the world’s biggest cola brands has raised questions about food safety, nanotechnology and the behaviour of microscopic materials inside living organisms. An apparent connection to a Gates Foundation-funded research project has added another dimension to the debate, but what do the scientific papers and financial records actually establish?
A particle measuring approximately five nanometres is almost unimaginably small, roughly 20,000 times narrower than a human hair. Yet researchers examining Coca-Cola and Pepsi in a study published in Nanotoxicology reported finding fluorescent particles at approximately that scale. They subsequently isolated the particles and investigated what happened when they entered living organisms.
The findings attracted attention because the particles appeared to travel beyond the digestive system. In experiments involving mice, researchers detected fluorescence in several organs, including the brain, raising questions about whether these microscopic materials could cross the blood-brain barrier. The study has since resurfaced on social media, accompanied by claims connecting the discovery to Bill Gates, the Gates Foundation and an earlier project involving graphene quantum dots.
The allegations are striking, particularly because the two research projects share some characteristics. But understanding whether there is a genuine connection requires examining the original scientific findings, the differences between the materials and the financial relationships behind the claims.
The particles researchers isolated from cola
The original research, titled Fluorescent nanoparticles present in Coca-Cola and Pepsi-Cola: physiochemical properties, cytotoxicity, biodistribution and digestion studies, was conducted by Shen Li, Chengkun Jiang, Haitao Wang, Shuang Cong and Mingqian Tan. It appeared in the journal Nanotoxicology in February 2018, following online publication in December 2017.
The researchers investigated fluorescent nanoparticles in commercially available Coca-Cola and Pepsi-Cola, seeking to understand their physical and chemical characteristics and how they might behave in biological systems. Using freeze-drying and column chromatography, they concentrated and isolated particles from the beverages for further examination. The resulting materials measured approximately 4.7 to 5 nanometres, with chemical analysis identifying carbon, hydrogen and oxygen.
These particles belong to a class of materials known as carbon dots. They are extremely small carbon-based structures capable of emitting light when exposed to particular wavelengths, a property known as fluorescence. Their behaviour under specialised laboratory conditions makes them useful in several scientific applications, including biological imaging and sensing.

The researchers also examined their molecular characteristics and identified carbon structures associated with alcohol and ether groups. Subsequent cellular experiments indicated that the particles could enter living cells and accumulate in cell membranes and the surrounding cellular material, known as cytoplasm. This provided the basis for investigating what might happen after the particles entered an entire organism.
What happened when the particles entered mice?
The most attention-grabbing part of the research concerned biodistribution, the process through which a substance moves through the body and accumulates in different organs. To investigate this, the researchers used 27 female BALB/c mice, dividing them into nine groups. Eight groups received isolated nanoparticles from Coca-Cola or Pepsi, while the remaining group served as a control.
The mice received a single oral administration of the isolated particles at a dose of 2 grams per kilogram of body weight. Researchers subsequently examined their organs at different intervals, including 15 minutes, two hours, six hours and 24 hours after administration. The results showed fluorescence in several parts of the digestive system, as well as in the liver, heart, lungs, kidneys, spleen and brain.
The brain findings were particularly notable because the blood-brain barrier normally regulates which substances can move from the bloodstream into brain tissue. Formed by specialised cells surrounding blood vessels in the brain, this protective system limits exposure to potentially harmful substances while allowing essential nutrients to pass through.
The detection of fluorescence in brain tissue suggested that the isolated particles could cross this barrier under the experimental conditions. However, the finding requires careful interpretation. The experiment involved mice receiving concentrated, isolated particles rather than humans drinking ordinary servings of Coca-Cola or Pepsi. It did not establish that consuming either beverage causes neurological damage or that the same distribution occurs in people.
The toxicity results complicate the warning
There is another important part of the original research that receives considerably less attention in the viral discussion. Alongside examining where the particles travelled, the researchers investigated their potential acute toxicity, assessing whether the administered dose produced observable short-term harm.
Following the single administration of 2g/kg of isolated particles, the mice appeared healthy during the observation period. Blood tests identified some statistically significant differences in biochemical measurements, including indicators associated with liver and kidney function, but the researchers described these differences as not biologically significant. Examination of tissue samples also revealed no obvious organ damage or significant histopathological abnormalities under the tested conditions.
The researchers therefore reported no obvious acute toxicity at the administered dose. That conclusion, however, should not be confused with proof that the particles are harmless. Acute toxicity experiments cannot establish what might happen after repeated exposure over months or years, nor can findings from a limited animal experiment settle questions about human consumption.
The wider scientific literature has also identified carbon dots in other food products, suggesting that their presence is not necessarily unique to cola beverages. A review titled Endogenous Fluorescence Carbon Dots Derived from Food Items examined the occurrence of these materials in food, including products such as beer and instant coffee. It discussed how carbon dots can form during food processing and highlighted the need for further investigation into their biological effects.
This places the Coca-Cola and Pepsi findings within a broader scientific question about food-derived nanoparticles. Researchers still need to establish how these structures form, how they behave during digestion and whether repeated dietary exposure carries consequences that existing experiments have not adequately measured.
Where Bill Gates enters the story
The social media discussion introduces a second research paper involving the Bill & Melinda Gates Foundation. Published in May 2016, the study, Enhancement of the Upconversion Emission by Visible-to-Near-Infrared Fluorescent Graphene Quantum Dots for miRNA Detection, appeared in ACS Applied Materials & Interfaces.
Its acknowledgements explicitly recognised financial support from the Bill & Melinda Gates Foundation under grant OPP1128411, alongside funding from Spain’s Ministry of Economy and Competitiveness. The research involved graphene quantum dots, a related but distinct category of carbon-based nanomaterials produced using graphite as a starting material.
The resulting particles had an average diameter of approximately 4.3 nanometres and displayed fluorescent properties. Researchers incorporated them into a laboratory sensor designed to detect specific microRNA sequences. MicroRNAs are small molecules involved in regulating gene expression, and their detection has applications in biomedical research and disease diagnostics.
The similarities with the particles isolated from Coca-Cola and Pepsi are evident at a broad level. Both studies involved extremely small fluorescent carbon-based materials, with reported particle sizes around five nanometres. Both also examined properties that make such materials useful in scientific applications.
However, similarity in size and fluorescence does not establish that the materials were identical. The cola study identified carbon structures associated with alcohol and ether groups, including sp3-hybridised carbon, while the graphene quantum dot research identified predominantly sp2-hybridised carbon structures characteristic of graphene. These are important differences in the materials’ reported structural characteristics.
The research objectives were also unrelated. The Gates-funded project investigated a technology for detecting microRNA, not beverage manufacturing or the formulation of commercial soft drinks. Neither paper establishes that the graphene quantum dots developed in the earlier project were used in Coca-Cola or Pepsi. The connection presented in the viral discussion therefore remains an allegation rather than a scientifically demonstrated relationship.
The investment question
The financial claims also require separating documented investment exposure from assumptions about corporate involvement. Bill Gates is associated with the Gates Foundation Trust, which manages the endowment supporting the foundation’s philanthropic activities. The trust operates separately from the foundation’s grant-making activities, with its investment assets managed by Cascade Asset Management Company and independent investment managers.
The trust’s investment disclosures provide evidence of substantial exposure to the Coca-Cola bottling business through Coca-Cola FEMSA, one of the world’s largest Coca-Cola bottlers, with operations across Latin America. Its September 2026 Form 13F filing reportedly disclosed a holding of 6,214,719 shares, valued at approximately US$671.4 million as of September 30, 2026.
That figure is significant, but its meaning needs to be stated accurately. It represents an investment position in Coca-Cola FEMSA held through the trust, not evidence that Bill Gates personally invested that amount in developing Coca-Cola’s ingredients or manufacturing processes.
The PepsiCo allegation is less straightforward. The same September 2026 filing does not list PepsiCo among the disclosed holdings. That does not independently resolve every possible historical or indirect investment relationship, but it does mean the filing cannot substantiate the claim that the trust held a comparable PepsiCo position.
More importantly, investments in beverage companies and grants supporting unrelated scientific research are separate financial activities. A shareholding in a bottling company does not establish involvement in the formulation of its products, while funding a university research project does not establish that the resulting materials were subsequently used in commercial beverages.
What the research actually leaves unanswered
The most important unresolved question is not whether researchers found carbon dots in cola. The 2018 paper provides experimental evidence that fluorescent carbon-based particles could be isolated from the Coca-Cola and Pepsi samples examined. It also reports that the isolated particles entered different tissues in mice, including the brain, following controlled laboratory administration.
What remains uncertain is the significance of those findings for ordinary consumers. The study did not establish how much of the material people might ingest through normal consumption, whether the particles survive digestion in the same form, or whether repeated exposure produces measurable biological effects over time. Nor did it demonstrate neurological damage or other diseases in humans.
A 2025 review published in Foods, titled Food-Derived Carbon Dots: Formation, Detection, and Impact on Gut Microbiota, provides further context. It discusses how carbon dots can emerge during ordinary food-processing activities, including baking, roasting, frying and caramelisation, while identifying gaps in understanding their long-term biological effects.
For beverage manufacturers, the findings raise legitimate questions about the composition of processed drinks and the extent to which food-derived nanoparticles are understood and assessed. For regulators, they point to a wider scientific challenge involving microscopic substances that may not form part of routine product-safety testing.
The Gates Foundation connection makes the story more attention-grabbing, but the available research does not establish that its earlier graphene project supplied the particles found in Coca-Cola or Pepsi. The two studies share broad characteristics, yet their reported chemical structures, research objectives and experimental applications differ.
A laboratory can identify a microscopic particle, isolate it, administer it to an animal and observe where it travels. Establishing what that means for millions of people who consume these beverages requires a different level of evidence. The five-nanometre particles deserve scientific attention, but the claims surrounding their origin, corporate involvement and potential health consequences must remain proportionate to what the research actually demonstrates.










